0001209191-18-041768.txt : 20180705 0001209191-18-041768.hdr.sgml : 20180705 20180705183426 ACCESSION NUMBER: 0001209191-18-041768 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180705 DATE AS OF CHANGE: 20180705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patterson Matthew R CENTRAL INDEX KEY: 0001401018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37833 FILM NUMBER: 18941498 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-02 0 0001628738 Audentes Therapeutics, Inc. BOLD 0001401018 Patterson Matthew R C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO CA 94108 1 1 0 0 Chief Executive Officer Common Stock 2018-07-02 4 M 0 19599 0.78 A 19599 D Common Stock 2018-07-02 4 S 0 19599 38.3282 D 0 D Common Stock 2018-07-02 4 M 0 1401 0.78 A 1401 D Common Stock 2018-07-02 4 S 0 1401 38.7793 D 0 D Common Stock 2018-07-03 4 M 0 26901 0.78 A 26901 D Common Stock 2018-07-03 4 S 0 26901 40.0528 D 0 D Common Stock 2018-07-05 4 M 0 23147 0.78 A 23147 D Common Stock 2018-07-05 4 S 0 23147 40.042 D 0 D Common Stock 171814 I By Matthew R. Patterson Revocable Trust Stock Option (right to buy) 0.78 2018-07-02 4 M 0 19599 0.00 D 2023-09-25 Common Stock 19599 159151 D Stock Option (right to buy) 0.78 2018-07-02 4 M 0 1401 0.00 D 2023-09-25 Common Stock 1401 157750 D Stock Option (right to buy) 0.78 2018-07-03 4 M 0 26901 0.00 D 2023-09-25 Common Stock 26901 130849 D Stock Option (right to buy) 0.78 2018-07-05 4 M 0 23147 0.00 D 2023-09-25 Common Stock 23147 107702 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Represents the weighted average sale price. The lowest price at which shares were sold was $37.71 and the highest price at which shares were sold was $38.71. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes 2, 3, 4 and 5 to this Form 4. Represents the weighted average sale price. The lowest price at which shares were sold was $38.72 and the highest price at which shares were sold was $38.99. Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.55. Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.17. The reporting person is the trustee of the Matthew R. Patterson Revocable Trust. The option vested as to 25% of the total shares on January 1, 2014, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on January 1, 2017, subject to the reporting person's provision of service to the issuer on each vesting date and to accelerated vesting in the event of the occurrence of certain events. /s/ Thomas Soloway as attorney-in-fact for Matthew Patterson 2018-07-05